Global Community

Micron has moved from being a “possible AI memory beneficiary” to a company where the AI memory supercycle is now visible in revenue, margins and cash flow. The Simply Wall St snapshot frames the trade-off well: MU has exceptional growth potential and a strong balance sheet, but the share price has already moved dramatically.Read more

REN acquisition of Mirantis ($625M, all-stock) 1. Transaction overview Acquirer: IREN (AI infrastructure / former Bitcoin mining company) Target: Mirantis (cloud infrastructure & Kubernetes orchestration software) Deal value: ~$625M (stock consideration) [ growjo.com ] Announcement date: May 5, 2026 [ kearney.com ] Structure: Mirantis to operate as a standalone subsidiary [ kearney.com ] Mirantis brings: 1,500+ enterprise customers Kubernetes / AI infrastructure orchestration (k0rdent platform) [ kearney.com ] 2.Read more

Investment Thesis DefenCath's regulatory moat (only FDA-approved antimicrobial CLS in the U.S., NCE+GAIN exclusivity through 2033, composition patent to 2042) is intact and the 72% real-world CRBSI reduction is standard-of-care quality data; the TDAPA pricing step-down is a commercial mechanics event, not a competitive displacement event The stock at $7.02 prices in approximately the bear case ($6.54), meaning investors are effectively receiving the REZZAYO prophylaxis Phase III binary and the DefenCath TPN pipeline for free — an unusual asymmetry for a cash-flow-positive commercial pharma company Operating cash flow of $175M in FY2025 and $148.5M in cash provides full self-funding of pipeline without dilution risk, and the $75M buyback at current prices represents management's explicit capital allocation conviction about intrinsic value The Melinta acquisition was well-priced ($30M goodwill on $391M identified intangibles) and adds an annualizing $130M+ revenue stream with shared call points that provide SG&A leverage as the combined platform scales Post-TDAPA recovery in 2027 (3x–5x higher add-on payment vs. H2 2026 per management, plus Medicare Advantage contracting upside not in guidance) provides a clearly identified catalyst path back to re-rating independent of pipeline success Risk Considerations ReSPECT Phase III failure (data Q2 2026) would eliminate ~$221M of base case rNPV, trigger impairment of the $143M IPR&D intangible, and likely reset the stock to the $5.60 52-week low or below — this is the primary binary risk and is near-term Customer concentration at 79% revenue from three accounts is structurally dangerous; any publicly announced reduction in DefenCath orders from a major dialysis organization would be a material negative event with little warning The Q4 GAAP EPS miss ($0.16 vs.Read more

AMD is trying to close the gap with Nvidia in the race to power artificial intelligence, helped by new data-center chips that aim to offer strong performance at a better deal for big buyers. The big question is whether AMD can deliver and win adoption fast enough before Nvidia pulls further ahead—or the market mood turns.Read more

12-month forecast for 2026-2027: 1150-1480 Yen a share DCF 5 year Exit forecast: 2280-3640 Yen a share Cover Corporation's annual fiscal report was soul crushing as missteps from management, wasted production time and unfocused effort all led to a significant amount of waste in workloads and investment potential. Cover's "Metaverse" project with HoloEarth is officially dead in the water and will be discontinued after spending over 3 Billion Yen in development/support costs over the past 2 1/2 years.Read more

I conducted the following experiment with Gemini. I asked him to verify if DEGEN_GCR's narrative was plausible and to compare it with his own data and sources.Read more

A new push from Washington to speed up approvals for big data-centre builds could land right in IREN’s lap, since it’s already lining up large sites in Texas powered by renewable energy. The big question is whether it can execute fast enough to justify today’s high expectations as it shifts from bitcoin mining toward selling computing power for AI.Read more

Glenveagh aims to solve Ireland’s housing shortage by building more homes with its own factory-style supply chain, rather than relying on stretched local contractors. The key question is whether government support and smoother planning can keep demand steady while rising wages and infrastructure gaps don’t squeeze profits.Read more

A Japanese consulting and IT services firm is coming out of the gate with a much stronger start than expected, helped by growing demand from government and public-sector clients. Management is still talking down the rest of the year while investing more in people and new capabilities like AI, setting up a clear debate on whether the caution is realistic or overly conservative.Read more